BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21315768)

  • 1. Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage.
    Assaf F; Fishbein M; Gafni M; Keren O; Sarne Y
    Behav Brain Res; 2011 Jun; 220(1):194-201. PubMed ID: 21315768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term consequences of a single treatment of mice with an ultra-low dose of Delta9-tetrahydrocannabinol (THC).
    Amal H; Fridman-Rozevich L; Senn R; Strelnikov A; Gafni M; Keren O; Sarne Y
    Behav Brain Res; 2010 Jan; 206(2):245-53. PubMed ID: 19766676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single low dose of tetrahydrocannabinol induces long-term cognitive deficits.
    Tselnicker I; Keren O; Hefetz A; Pick CG; Sarne Y
    Neurosci Lett; 2007 Jan; 411(2):108-11. PubMed ID: 17092651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage.
    Fishbein-Kaminietsky M; Gafni M; Sarne Y
    J Neurosci Res; 2014 Dec; 92(12):1669-77. PubMed ID: 25042014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
    Jardinaud F; Roques BP; Noble F
    Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in the effects of delta9-tetrahydrocannabinol on spatial learning in adolescent and adult rats.
    Cha YM; Jones KH; Kuhn CM; Wilson WA; Swartzwelder HS
    Behav Pharmacol; 2007 Sep; 18(5-6):563-9. PubMed ID: 17762524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure.
    Quinn HR; Matsumoto I; Callaghan PD; Long LE; Arnold JC; Gunasekaran N; Thompson MR; Dawson B; Mallet PE; Kashem MA; Matsuda-Matsumoto H; Iwazaki T; McGregor IS
    Neuropsychopharmacology; 2008 Apr; 33(5):1113-26. PubMed ID: 17581536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling.
    Fishbein M; Gov S; Assaf F; Gafni M; Keren O; Sarne Y
    Exp Brain Res; 2012 Sep; 221(4):437-48. PubMed ID: 22821081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
    D'Souza DC; Abi-Saab WM; Madonick S; Forselius-Bielen K; Doersch A; Braley G; Gueorguieva R; Cooper TB; Krystal JH
    Biol Psychiatry; 2005 Mar; 57(6):594-608. PubMed ID: 15780846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): behavioral, pharmacological and biochemical studies in mice.
    Senn R; Keren O; Hefetz A; Sarne Y
    Pharmacol Biochem Behav; 2008 Jan; 88(3):230-7. PubMed ID: 17888506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance.
    Müller-Vahl KR; Koblenz A; Jöbges M; Kolbe H; Emrich HM; Schneider U
    Pharmacopsychiatry; 2001 Jan; 34(1):19-24. PubMed ID: 11229617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of delta9-THC on learning in adolescent and adult rats.
    Cha YM; White AM; Kuhn CM; Wilson WA; Swartzwelder HS
    Pharmacol Biochem Behav; 2006 Mar; 83(3):448-55. PubMed ID: 16631921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
    Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
    Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
    Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
    J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphenyl diselenide and 2,3-dimercaptopropanol increase the PTZ-induced chemical seizure and mortality in mice.
    Brito VB; Folmer V; Puntel GO; Fachinetto R; Soares JC; Zeni G; Nogueira CW; Rocha JB
    Brain Res Bull; 2006 Feb; 68(6):414-8. PubMed ID: 16459195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible nitric oxide mechanism in the protective effect of hesperidin against pentylenetetrazole (PTZ)-induced kindling and associated cognitive dysfunction in mice.
    Kumar A; Lalitha S; Mishra J
    Epilepsy Behav; 2013 Oct; 29(1):103-11. PubMed ID: 23939034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood.
    Rubino T; Realini N; Braida D; Guidi S; Capurro V; Viganò D; Guidali C; Pinter M; Sala M; Bartesaghi R; Parolaro D
    Hippocampus; 2009 Aug; 19(8):763-72. PubMed ID: 19156848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
    Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
    Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome.
    Rueda N; Flórez J; Martínez-Cué C
    Neurosci Lett; 2008 Mar; 433(1):22-7. PubMed ID: 18226451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.